This article discusses current trends in environmental sustainability in the pharmaceutical industry, which is seeing increased pressure to make commitments and tangible progress that positively impact both the environment and society. The global shift towards achieving a sustainable future has made environmental stewardship an expected norm. However, a key challenge for the pharmaceutical industry is how to accommodate demanding production schedules and increased product variety while also keeping the environment and sustainability in mind.
Noble, an Aptar Pharma company, plays its part in contributing to a sustainable environment by creating resettable training devices. These reusable training devices allow patients to repeatedly practice the use of autoinjectors, prefilled syringes and nasal delivery devices to educate themselves on proper usage technique and to help them overcome their anxiety and fears – rather than using their single-use drug delivery devices filled with medication for practice, which requires disposal after a single use.
Noble is also an environmental steward when it comes to its packaging designs, balancing sustainability with an understanding that the patient and product efficacy are key factors in the design process.
Due to pressing environmental needs, a focus on preserving the environment for future generations and a shift to more responsible consumption and production, companies have embraced more sustainable strategies. The link between sustainability, both environmental and social, has clear ties to human health, making advancement of these strategies a priority for healthcare and pharmaceutical industries alike.
